Abbing-Karahagopian, V. ., Huerta, C. ., Souverein, P. C., de Abajo, F. ., Leufkens, H. G., Slattery, J. ., … De Bruin, M. L. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
V. Abbing-Karahagopian
First name
V.
Last name
Abbing-Karahagopian
Abbing-Karahagopian, V. ., Kurz, X. ., de Vries, F. ., van Staa, T. P., Alvarez, Y. ., Hesse, U. ., … Klungel, O. H. (2014). Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol.
Huerta, C. ., Abbing-Karahagopian, V. ., Requena, G. ., Oliva, B. ., Alvarez, Y. ., Gardarsdottir, H. ., … de Abajo, F. J. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825
Requena, G. ., Huerta, C. ., Gardarsdottir, H. ., Logie, J. ., Gonzalez-Gonzalez, R. ., Abbing-Karahagopian, V. ., … de Abajo, F. J. (2016). Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3816